Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Innoviva Inc. (INVA)

13.61   -0.19 (-1.38%) 07-07 16:00
Open: 13.69 Pre. Close: 13.8
High: 13.88 Low: 13.56
Volume: 566,390 Market Cap: 1,379M
Innoviva Inc is a biopharmaceutical company that is engaged in the discovery, development and commercialization of small molecule medicines. The firm collaborates with and receives funding from GlaxoSmithKline.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.619 - 14.69 14.69 - 14.76
Low: 13.577 - 13.664 13.664 - 13.749
Close: 13.671 - 13.807 13.807 - 13.942

Technical analysis

as of: 2020-07-07 3:35:47 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 16.97     One year: 18.24
Support: Support1: 12.76    Support2: 10.62
Resistance: Resistance1: 14.53    Resistance2: 15.62
Pivot: 13.93
Moving Average: MA(5): 14.26     MA(20): 13.94
MA(100): 13.23     MA(250): 12.74
MACD: MACD(12,26): 0.11     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 43.94     %D(3): 53.19
RSI: RSI(14): 47.00
52-week: High: 15.62  Low: 7.58  Change(%): -5.2
Average Vol(K): 3-Month: 72783  10-Days: 91230

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
INVA has closed above bottom band by 39.4%. Bollinger Bands are 9.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 06 Jul 2020
Why Should You Put Innoviva Inc. (NASDAQ: INVA) On Your Portfolio? - The Life Telegraph

Tue, 23 Jun 2020
Walk through Financial Numbers of Innoviva, Inc. (INVA) - The News Heater

Tue, 23 Jun 2020
Where Does Wall Street Think Innoviva Inc (INVA) Stock Will Go? - InvestorsObserver

Tue, 23 Jun 2020
Innoviva (INVA) Looks Good: Stock Adds 8.9% in Session - Yahoo Finance

Tue, 23 Jun 2020
Here is What Hedge Funds Think About Innoviva, Inc. (INVA) - Yahoo Finance

Mon, 22 Jun 2020
Is Innoviva Inc (INVA) a Stock to Watch This Week? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101
Shares Float (M) 55
% Held by Insiders 32.33
% Held by Institutions 76.37
Shares Short (K) 12,630
Shares Short P. Month (K) 11,820

Stock Financials

EPS 1.660
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.750
Profit Margin 66.41
Operating Margin 95.01
Return on Assets (ttm) 24.5
Return on Equity (ttm) 75.9
Qtrly Rev. Growth 42.6
Gross Profit (p.s.) 2.576
Sales Per Share 2.808
EBITDA (p.s.) 2.668
Qtrly Earnings Growth 93.70
Operating Cash Flow (M) 254
Levered Free Cash Flow (M) 156

Stock Valuations

PE Ratio 8.24
PEG Ratio
Price to Book value 3.65
Price to Sales 4.87
Price to Cash Flow 5.45

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2015-09-29
Ex-Dividend Date 2015-09-07
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.